Medicare Secures Significant Price Reductions on 15 Essential Medications
November 26, 2025 - 22:38
Medicare has successfully negotiated lower prices for 15 crucial medications following a second round of discussions with pharmaceutical companies. Among the notable drugs included in this agreement are Ozempic and Wegovy, both of which are widely used for diabetes management and weight loss, respectively. The negotiations have resulted in a remarkable 71% price reduction for these medications, making them more accessible to patients in need.
In addition to Ozempic and Wegovy, the list encompasses a variety of treatments for serious health conditions, including asthma, breast cancer, and leukemia. This initiative marks a significant step towards making essential medications more affordable for millions of Americans, particularly those on fixed incomes or facing financial hardships. The impact of these negotiations is expected to be profound, as lower drug prices can lead to improved health outcomes and reduce the financial burden on patients and the healthcare system.
MORE NEWS
February 25, 2026 - 02:58
Family of Mother with Mental Health History Who Died in Custody Speaks Out: 'We Lost a Best Friend'The family of Tammy Shipley is speaking out after her tragic death in police custody, describing her as a beloved mother and friend whose mental health struggles were met with a fatal lack of care....
February 24, 2026 - 08:01
The Hidden Health Risks of Plastic-Packaged Ready MealsA new scientific review has raised significant concerns about the health risks posed by plastic food packaging, with a particular warning aimed at consumers of heated ready meals and takeaways. The...
February 23, 2026 - 16:19
No one in health care should be called a ‘provider’A leading medical society is calling for a fundamental change in language within the healthcare system. The American College of Physicians (ACP) contends that the ubiquitous term `provider`...
February 22, 2026 - 22:51
Bhattacharya’s growing power in Trump’s HHS worries health expertsPublic health experts and former federal staffers are expressing significant unease regarding the growing influence of National Institutes of Health (NIH) Director Jay Bhattacharya over U.S. health...